# OnCo record drug-desensitisation-after-anticancer-hypersensitivity (protocol). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/protocols/drug-desensitisation-after-anticancer-hypersensitivity/>
  a schema:MedicalGuideline ;
  onco:kind "protocol" ;
  schema:identifier "drug-desensitisation-after-anticancer-hypersensitivity" ;
  schema:name "Rapid drug desensitisation after an allergic reaction to a platinum, taxane or antibody"@en ;
  schema:alternateName "chemotherapy desensitization"@en, "rapid drug desensitisation"@en, "RDD"@en, "carboplatin desensitisation"@en, "paclitaxel desensitisation"@en, "12-step desensitization"@en, "3-bag protocol"@en, "rituximab desensitisation"@en, "carboplatin allergy"@en ;
  schema:description "If you have had a true allergic reaction to a cancer drug that is still your best treatment, allergy specialists can often give it again safely by desensitisation: starting with a tiny, very diluted dose and building up slowly over several hours, under close watch. The protection lasts only while the drug is in your body, so it is repeated at every treatment."@en ;
  schema:url <https://onco.cc/protocols/drug-desensitisation-after-anticancer-hypersensitivity/> ;
  schema:dateModified "2026-11-11"^^xsd:date ;
  onco:related <https://onco.cc/protocols/infusion-reaction-management/>, <https://onco.cc/protocols/premedication-before-reaction-prone-anticancer-drugs/> ;
  onco:drugs <https://onco.cc/drugs/carboplatin/>, <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/drugs/oxaliplatin/>, <https://onco.cc/drugs/paclitaxel/>, <https://onco.cc/drugs/docetaxel/>, <https://onco.cc/drugs/rituximab/> ;
  onco:terms <https://onco.cc/terms/extravasation-infusion-reaction/> .
